On March 17, 2025, ANI Pharmaceuticals, Inc. exercised its buyout option related to the Iluvien royalty, which resulted in a payment of approximately $17.3 million to SWK.

In March 2025, through two transactions SWK monetized its performing royalty portfolio for approximately $51.3 million and anticipates declaring a dividend on the closing of the larger transaction.

SWK boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of Stanley Black & Decker are trading at a forward earnings multiple of 15.7X, as well as a ...

In this article, we are going to take a look at where Stanley Black & Decker, Inc. (NYSE:SWK) stands against other blue chip stocks to invest in at 52-week lows. For the first time since 2023 ...

Stanley Black & Decker Stock Performance NYSE:SWK opened at $76.46 on Monday. The firm’s fifty day simple moving average is $85.03 and its 200 day simple moving average is $90.10. The company ...

Get Our Latest Analysis on Stanley Black & Decker Stanley Black & Decker Trading Down 1.6 % NYSE SWK opened at $76.46 on Monday. Stanley Black & Decker, Inc. has a 12 month low of $76.25 and a 12 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...